Turkey: International Medtechs Demand Stable Pricing And On-Time Payments
Medtechs are reacting to Turkey’s lack of attention to the local hospital system
Growth prospects for Turkey’s medical technology market are significant, but local companies have complained about public policies that are harmful to business and about the ongoing crisis in the hospital system. Now, international medtechs are starting to react, with some downscaling local operations and portfolios. Association of Research Based Medical Technologies Manufacturers president Umut Gokalp laid out the problems being faced by industry, and what action he thinks the government should take.
You may also be interested in...
A plan to set up a Directorate of Health Industries within the Office of the Presidency has been welcomed by Turkish medtechs, who see it as opportunity to highlight to President Erdoğan ongoing industry problems such as late payments.
Amid delays in surgical operations caused by shortages of equipment and medtech companies demanding payment of outstanding hospital debts, a strong devaluation of the Turkish lira has put the local health care system on a crisis footing.
Late payment of hospital debts continues to haunt the Turkish medtech industry, which recently led a public demonstration in Ankara to focus the government’s attention on the issue. Medtech multinationals fear that the ongoing problems will mean Turkey losing the positive momentum it achieved during the pandemic.